Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study

Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study

Botulinum toxin type A (BoNT-A) is the treatment of choice for focal spasticity, with a concomitant effect on pain reduction and improvement of quality of life (QoL). Current evidence of its efficacy is based mainly on post stroke spasticity. This study aims to clarify the role of BoNT-A in the cont...

Full description

Bibliographic Details
Main Authors: Alessio Baricich, Marco Battaglia, Daria Cuneo, Lucia Cosenza, Marzia Millevolte, Michela Cosma, Mirko Filippetti, Stefania Dalise, Valentina Azzollini, Carmelo Chisari, Stefania Spina, Nicoletta Cinone, Lorenza Scotti, Marco Invernizzi, Stefano Paolucci, Alessandro Picelli, Andrea Santamato
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Neurology
Subjects:
botulinum toxin
pain
spasticity
movement disorders
multiple sclerosis
spinal cord injury
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1133390/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1133390/full

Similar Items